For treatment costs, we assumed full adherence to medications, and derived medication costs directly from the Australian Pharmaceutical Benefits Scheme ( The most common SGLT2i in Australia in 2020 was empagliflozin
LEADER, SUSTAIN-6, and REWIND trial outcomes The initial wave of cardiovascular outcome trials (CVOTs) predominantly focused on patients with type 2 diabetes at elevated cardiovascular risk
The appetite regulation influences represent another significant advantage of this dual-agonist mechanism
Summary Many animal foods are high in vitamin B12
You can also take an N-acetyl L-cysteine (NAC) supplement, a key precursor to glutathione
An inducible Clec7a-CreERT2 mouse line enables selective genetic tracing of proliferative-region-associated microglia (PAM) and DAM in the CNS ( in vivo tracing demonstrated state transitions, exhibiting reversible microglial plasticity